Aetiological factors in development of myasthenia gravis
- 31 December 1994
- journal article
- review article
- Published by Elsevier in Advances in Neuroimmunology
- Vol. 4 (4) , 355-371
- https://doi.org/10.1016/0960-5428(94)00041-l
Abstract
No abstract availableThis publication has 52 references indexed in Scilit:
- Myasthenia gravis: recognition of a human autoantigen at the molecular levelImmunology Today, 1993
- HL A-A2-Restricted T-Cell Line Recognizing an Epitope of the Human Acetylcholine ReceptorAnnals of the New York Academy of Sciences, 1993
- Determinant spreading and the dynamics of the autoimmune T-cell repertoireImmunology Today, 1993
- Suppression of Experimental Autoimmune Myasthenia Gravis by Epitope-Specific Neonatal Tolerance to Synthetic Region α146-162 of Acetylcholine ReceptorClinical Immunology and Immunopathology, 1993
- Unexpected cross-reactivity between myosin and a main immunogenic region (MIR) of the acetylcholine receptor by antisera obtained from myasthenia gravis patientsClinical Immunology and Immunopathology, 1992
- T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: Heterogeneity of antigenic sites on the α-subunitAnnals of Neurology, 1992
- Search for Cross-Reactive Idiotypes on Monoclonal and Myasthenia Gravis Acetylcholine Receptor AntibodiesAutoimmunity, 1992
- Neoplastic epithelial cells express α-subunit of muscle nicotinic acetylcholine receptor in thymomas from patients with myasthenia gravisFEBS Letters, 1991
- Monoclonal antibody against α(1 → 3) dextran transfers suppression of the immune response to the acetylcholine receptorEuropean Journal of Immunology, 1990
- Are spontaneous anti-idiotypic antibodies against anti-acetylcholine receptor antibodies present in myasthenia gravis?Journal of Autoimmunity, 1988